Story by Kapil Sachdeva, MD, neurologist, Northwestern Medicine Central DuPage Hospital HealthDay Reporter A TIA, or ...

A machine learning model for analysing brain lesion scans after stroke could mean up to 50% more patients receive appropriate ...

Early DOAC therapy within 4 days was non-inferior to delayed therapy for the composite outcome of recurrent ischemic or ...

Cell therapy is a promising option for the treatment of ischemic diseases. Infusion or injection of stem or progenitor cells has improved neovascularization and heart function after ischemia in ...

Learn about atorvastatin-loaded PEGylated liposomes as a targeted therapeutic approach for treating ischemic stroke, focusing ...

This study assesses acute ischemic stroke costs in Latin America, revealing treatment variations and economic challenges that ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering ...

The patent filing expands upon data obtained from animal model testing and the istaroxime human clinical trials in acute heart failure (AHF) and early cardiogenic shock (ECS), including the latest ...

Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the established treatment for acute ischemic stroke patients presenting within 4.5 h of stroke onset based on the ...

Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London.Toronto, Ontario--(Newsfile Corp. - December 11, ...

Hepatic ischemia-reperfusion injury (HIRI) is a key factor leading to complications and poor prognosis after hepatobiliary surgery, but its pathogenesis remains unclear. Hence, it is a very necessary ...